Category Archives: BiomedNews

Genetic connection to Parkinson's disease

Neurology

This is really complicated, but it looks like the researcher has the right idea for getting the point across. His comparison to a garbage dump truck is irresistible: New genetic research demonstrates possible cause of inherited form of Parkinson’s disease. : The situation is like “a garbage truck stalling at the entrance to the town dump. ‘If the truck breaks down right in front of the dump, not only does it fail to deliver its own garbage to the dump, but it blocks all the other garbage trucks and the town fills up with garbage.’ ”

Backing up at the protein disposal site–we seem to be hearing more and more about proteins, right along with genes. Maybe I’m crazy, but there seem to be some trends developing…

Enzyme helps Nitric Oxide fight TB – big time

Researchers wanted to know why an existing drug isoniazid works so well against tuberculosis. They found that nitric oxide–the same substance involved in inflammation (asthma, liver disease, etc.), pain and cardiac events is created when the drug is used to treat TB. “An enzyme only found inside the TB bacteria makes nitric oxide from the isoniazid that is taken inside the cell.”

The University of Mexico College of Pharmacy and School of Medicine discovered the mechanism by which the nitric oxide is energized. They expect to use this piece of the puzzle to develop even better drugs.

Antibiotics can contribute to colitis–new test allows faster treatment

Antibiotics often cause diarrhea and colitis, especially in hospitals and nursing homes where the culprit bacterium (C. difficile) is common–and so is antibiotic therapy. The FDA has approved Meridian Bioscience’s new ImmunoCard Toxins A&B, a rapid test for the diagnosis of a major cause of antibiotic-associated colitis”

Seems that as we learn to cure one thing, we contribute to the occurrence of other things. By the time we wipe out disease, some of us will be dying from the cures. This is one of the reasons bioscience is such a bursting source of new energy and economic growth.

It ain’t never gonna go out of style.

Pharmaceutical giants collaborating with emerging companies — hopeful sign

Given the complex roles that nitric oxide plays in so many different critical areas of medicine–like inflammation (which is a factor in a host of diseases like asthma, liver disease, etc.), pain and cardiovascular therapy, it’s very exciting to hear that drug gian Pfizer has committed to a partnership with emerging French NicOx that’s working on developing safer, more effective nitric-oxide-donating drugs. NicOx will synthesize nitric compounds that will be evaluated in preclinical screening and characterization tests. Once that’s finished, Pfizer will choose certain products to support for further development and global commercialization.

Pfizer says it’s going to continue to look for collaboration opportunities. This may be a good omen for those struggling to get started–or those just struggling–in the bioscience industry.

Nature holds both healing miracles and the seeds of destruction–sometimes in the same element

Just discovered this item that was first reported in the spring this year. Children with sickle cell disease experience pain when their veins begin to close up (an effect of the disease). I had some exposure to the potential effects–both positive and negative–of nitrix oxide when writing a white paper on asthma this year. So I was fascinated to hear about this study.

The Journal of the American Medical Association published results of a Preliminary Assessment of Inhaled Nitric Oxide for Acute Vaso-occlusive Crisis in Pediatric Patients With Sickle Cell Disease in which they gave kids hospitalized with pain from a vaso-occlusive event (veins closing up) and found that pain levels were lowered enough to warrant further investigation.

Nitric oxide is a strange substance. When it comes out of car exhausts, we think of it as bad. When it’s exhaled from our bodies, we think of eliminating waste. But it also helps dilate bronchial tubes–and now veins. And it plays as-yet unknown parts in inflammation that occurs in the body’s tissues.

Just as cancer cells are regular cells run amok, so many things that are natural to us can be both good and bad. What a conundrum for researchers.

Conference highlight: RNA safer than DNA for genetic engineering

The annual meeting is not a thing of the past, in spite of threats of terrorism and still-sluggish economic conditions. This one for the American Neurological Association (ANA) has some exciting presentations planned. They will feature topics like regenerating nerve fibers and cells in in the spinal cord and brain (traditionally not as self-healing as other tissue), and discussing how interfering with RNA is easier and safer than targeting DNA for genetic engineering. For those of us who are non-scientists, I wondered why using DNA is considered dangerous. So I scouted around and found this paper online (by a University of California, Berkeley professor) that gives one good reason. DNA can contain–and transfer over–“genetic material from bacteria, viruses and other genetic parasites that cause diseases as well as antibiotic resistance [sic] genes that make infectious diseases untreatable.” Now I hope that we among the interested public won’t have to wait until a report from the conference on why RNA is safer.

Drug offers improved short-term memory

In a recent study of memory disorders, some patients in a carefully organized and controlled setup showed improvement in short-term memory when treated with a drug that’s used for Alzheimer’s.

But here’s the part I want to point out: those who received the drug reported nearly as many side effects as those in the placebo group (88% to 73%). But “Diarrhea, nausea, vomiting, abnormal dreams, insomnia and leg cramps occurred in greater than five percent and [at] twice the rate of placebo.”

The dichotomy of medical research is that you must choose to ignore the suffering you create in the hope that what you learn will help others in the future. That’s a tough load to carry every day.

Change your language–and maybe change your world

You know, I gotta tell you that to see this sort of statement, “relatively high-functioning community-dwelling women (mean age 66.3 years)” is astonishing.

There must be a lot of people out there who are very different from the people I know who are in their 60s to even occasion the use of the phrase “relatively high-functioning.” I don’t care what the scientific definition is; it’s a reductionist approach to defining human beings.

You don’t have to be a full-fledged subscriber to so-called New Age techniques (which, by the way, are gaining ever-increasing favor among traditional western medical practitioners–never mind if it’s just about money) to understand that the way you talk about things–especially people–influences not only the way you’re going to interpret your findings, but even the way your “subjects” will act and react in your studies.

What you believe is pretty much what you’re going to find. So my advice is to stop referring to people you study as something less than the vibrant, whole, multi-faceted creatures they are.

Genetics discovery–helped by the Internet–holds key to many birth defects

Neurology

Clinical and basic scientist researchers at the University of Chicago followed a mysterious course of clues–and used the Internet to find patients to study–to identify the “first genetic cause of one of the most common birth defects of the brain, Dandy-Walker malformation (DWM). Infants with this disorder–about one in 10000 births–have a small, displaced cerebellum and other brain abnormalities that can reduce coordination, impair mental function and cause hydrocephalus.”

This story is a fascinating one of how scientists used deduction to follow a trail from a single child who was found to have a missing piece of chromosome to make this discovery. Even more exciting is the fact that DWM seems to be genetically a more extreme form of the same kind of abnormalities that result in autism.

Leave it to a student, though. A female MD/PhD student who combed the Internet to find parent support groups for children with DWM and separately for parents of children with related chromosomal abnormalities. How brilliantly shines the beauty of what the Internet can do to help human beings accomplish great things.

Any FDA approval is positive–even if it's later taken back

In an unusual reversal of the FDA advisory group’s decision a couple of months ago, the FDA refused to approve the use of Houston Cyberonics product (its only product) for depression. The device, approved for use with epilepsy, is a “small pacemaker-like device” that’s implanted in the chest and uses thin wires to send pulses to the vagus nerve in the neck.

The study took advantage of having located a convenient group of people diagnosed with depression and already undergoing other kinds of treatments. They gave that group the device, and then they used another group for comparison who did not receive their device but were also being treated by other methods. While the panel saw positive results, the full FDA found fault with the fact that the chosen patients weren’t randomly assigned to groups, as well as with the fact that other treatments were going on in both groups.

It looks as though this is just a blip for Cyberonics, though. After having its stock shoot up 80% when the panel approved the original request, last week Dallas-based Advanced Neuromodulation Systems bought a big chunk of Cyberonics shares and started talking about a potential merger.